麻豆传媒

Latest 麻豆传媒 from: FAST (Foundation for Angelman Syndrome Therapeutics)

Filters close
Released: 7-Mar-2024 8:05 AM EST
Family Advocates Urge Congress' Support During Inaugural Angelman Syndrome (AS) Congressional Advocacy Day
FAST (Foundation for Angelman Syndrome Therapeutics)

The Angelman Syndrome Foundation (ASF) and the Foundation for Angelman Syndrome Therapeutics (FAST) are hosting the inaugural Angelman Syndrome (AS) Congressional Advocacy Day in Washington, D.C.

Released: 14-Dec-2020 9:15 AM EST
FAST Conference Draws 20 Pharmaceutical Companies and Raises Over $2.2 Million for Research on Angelman Syndrome
FAST (Foundation for Angelman Syndrome Therapeutics)

FAST (the Foundation for Angelman Syndrome Therapeutics) today announced that Virtually Unstoppable, their annual Summit & Gala benefitting Angelman syndrome (AS) raised over $2.2 million during their virtual two-day conference.

Released: 14-Feb-2017 3:05 PM EST
Penn Gene Therapy Pioneer Teams Up with FAST in Race to Cure Angelman Syndrome
FAST (Foundation for Angelman Syndrome Therapeutics)

A pioneer on the frontier of genetic medicine and his team at one of the nation鈥檚 top-five medical research schools have joined forces with FAST (Foundation for Angelman Syndrome Therapeutics) to develop a treatment for the rare disorder Angelman syndrome.



close
0.07088